Immunolocalization of urokinase-type plasminogen activator (uPA) during chick heart development.

被引：0
|
作者：
Brauer, PR [1 ]
Ghosh, S [1 ]
机构：
[1] CREIGHTON UNIV,OMAHA,NE 68178
来源：
FASEB JOURNAL | 1996年 / 10卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1794 / 1794
页数：1
相关论文
共 50 条
  • [21] The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies
    Su, Shih-Chi
    Lin, Chiao-Wen
    Yang, Wei-En
    Fan, Wen-Lang
    Yang, Shun-Fa
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (05) : 551 - 566
  • [22] Urokinase-type plasminogen activator promotes development of experimental restenosis
    Parfyonova, YV
    Plekhanova, OS
    Kalinina, NI
    Bibilashvily, RS
    Bobik, A
    Tkachuk, VA
    KARDIOLOGIYA, 2000, 40 (09) : 69 - 77
  • [23] Calcitonin inhibits invasion of breast cancer cells: Involvement of urokinase-type plasminogen activator (uPA) and uPA receptor
    Han, B
    Nakamura, M
    Zhou, GY
    Ishii, A
    Nakamura, A
    Bai, YH
    Mori, I
    Kakudo, K
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 28 (04) : 807 - 814
  • [24] Hyperglycemia is associated with lower levels of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in wound fluid
    Akinci, Bans
    Terzi, Cem
    Sevindik, Gokmen
    Yuksel, Faize
    Tunc, Ulku Aybuke
    Tunali, Sunay
    Yesil, Sena
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (06) : 844 - 849
  • [25] Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer
    Steiner, E.
    Pollow, K.
    Hasenclever, D.
    Schormann, W.
    Hermes, M.
    Schmidt, M.
    Puhl, A.
    Brulport, M.
    Bauer, A.
    Petry, I. B.
    Koelbl, H.
    Hengstler, J. G.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : 569 - 576
  • [26] Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 and-2 in hepatocellular carcinoma
    Zhou, L
    Hayashi, Y
    Itoh, T
    Wang, WP
    Rui, JA
    Itoh, H
    PATHOLOGY INTERNATIONAL, 2000, 50 (05) : 392 - 397
  • [27] Nuclear translocation of urokinase-type plasminogen activator
    Stepanova, V.
    Kuo, A.
    Higazi, A.
    Yarovoi, S.
    Bdeir, K.
    Cines, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 : 228 - 228
  • [28] Plasma clearance of urokinase-type plasminogen activator
    van der Kaaden, ME
    Rijken, DC
    van Berkel, TJC
    Kuiper, J
    FIBRINOLYSIS & PROTEOLYSIS, 1998, 12 (04): : 251 - 258
  • [29] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITOR (PAL-1) EXPRESSION IN COLON DISEASES
    MISELJIC, S
    GALANDIUK, S
    MYERS, SD
    WITTLIFF, JL
    CLINICAL CHEMISTRY, 1995, 41 (06) : S224 - S224
  • [30] Urokinase-type plasminogen activator, an endogenous antibiotic
    Jin, T
    Bokarewa, M
    Tarkowski, A
    JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (03): : 429 - 437
12345